ACADIANA, La. (AP) – The Cancer Center of Acadiana is looking for men and women who have been diagnosed with multiple myeloma to participate in a clinical trial to compare the effectiveness of medications.
The Advocate reports the center at Lafayette General Medical Center is comparing the effectiveness of a combination of investigational medications among patients with previously untreated multiple myeloma ineligible for high-dose therapy.
The study is a Phase III clinical trial. Drugs that pass in the category may be approved for use in the general population.
A patient must be 18 and older to participate in the trial.
(Copyright 2015 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)
